Press Releases
-
Alfa Chemistry Commenced Offering Nonlinear Crystals and Precision Optical Materials
-
Packaging Solutions Ensuring Product Integrity: Glass and Plastic Varieties
-
Alfa Chemistry: Test Kits Provides New Options to Transform Testing Strategy
-
Creative Proteomics Launches Crotonylation Proteomics Analysis Service to Enhance Your Epigenetic Research
-
Creative Proteomics Revolutionizes DNA-Protein Interaction Studies with Cutting-Edge DNA Pull Down Service
-
Creative Proteomics Expands Proteomics Services with Launch of N-Terminal Edman Degradation Service
-
Creative Biolabs' Exhibition at BIO 2023 Accomplished
Creative Biolabs released exhibition highlight moments from their booth 2548 at the 2023 BIO International Convention held from June 5 to 8.
Jun 15, 2023
-
PrecisionLife Announces Strategic CNS Drug Development Collaboration with Nanopharmaceutics
PrecisionLife and Nanopharmaceutics, Inc. has announced today a strategic collaboration aiming to accelerate and de-risk the development of Nanopharmaceutics’ portfolio of central nervous system assets.
Jun 14, 2023
-
BullFrog AI Strengthens Capabilities of its AI Platform through Expansion of Licensing Agreement with Johns Hopkins Applied Physics Laboratory
BullFrog AI Holdings, Inc. announced the expansion of its worldwide license agreement with the Johns Hopkins Applied Physics Laboratory (APL), in Laurel, Maryland, for use of patented technology powering the Company’s bfLEAP™ platform, an AI-driven platform for analyzing drug development data to potentially make life-saving therapies and treatments available to patients more quickly.
Jun 4, 2023
-
MIB Agents’ Community of Families Has Awarded Over $1.5M in Grants to Research Pediatric Bone Cancer
MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, announced today that since its inception in 2016, it has awarded over $1.5 million to scientists across the country through its OutSmarting Osteosarcoma grant program. The OutSmarting Osteosarcoma grants are supported by MIB Agents Family Funds, osteosarcoma patients and families who raise funds in honor of an OsteoWarrior, a patient currently battling osteosarcoma or an OsteoAngel, a loved one who has passed.
Jun 13, 2023
-
Breaking Barriers in Clinical Trials: AI and Automation as a Catalyst for Innovation
This article highlights how AI and automation are driving innovation in clinical trial research by improving patient outcomes, reducing costs, and overcoming traditional barriers to progress.
Jun 14, 2023
-
AntlerA Norrin/Wnt-agonist ANT antibody enters clinical trials through a strategic partnership with EyeBio
AntlerA Therapeutics has announced a strategic collaboration and licensing agreement with EyeBio to begin clinical testing of AntlerA's Norrin/Wnt-agonist, a treatment of leaky blood vessels in the eye.
Jun 14, 2023
-
SMi discloses £6 million seed funding round, bolsters team with new C-suite hire
SMi Systems has disclosed a £6m seed funding round to develop and prove the utility of a novel multi-omic platform for in vitro diagnosis and biomedical research.
Jun 13, 2023
-
Unique molecule life cycle platform released: Torx® 2.0
Torx ® Software Limited, a collaboration between Cresset and Elixir Software, has launched a new ground-breaking platform for small molecule discovery chemistry.
Jun 13, 2023
-
Sygnature Discovery launches its LPS in vivo model to profile early-stage anti-inflammatory drugs
-
Inizio Prioritizes Medical Excellence and Transformation with New Senior Appointment
Inizio Medical has announced a top-level hire in its senior leadership team, with the appointment of Shauna Aherne as President of Medical Excellence, Specialized Services.
Jun 11, 2023
-
CD ComputaBio Introduces First Principle Calculations for Revolutionizing Computational Chemistry and Empowering Biotech Research
-
BioIVT to Highlight its Expanded ADME-Tox Products and Services Portfolio at the European ISSX and DMDG Meeting
Dr. Joanna Barbara, Site Lead at BioIVT’s laboratory in Kansas City, will also present case studies that demonstrate how to account for complications like protein binding and drug instability in drug transporter studies.
Jun 10, 2023
-
Pioneering Research Unveils Dynamic Human Eye Architecture: A Breakthrough in Ophthalmology
A groundbreaking study has taken a significant step towards understanding the complexities of the human eye. By mapping the molecular architecture of the retinal pigment epithelium (RPE) and choroid – integral components of the visual system – the research provides crucial insights into the cell compositions and molecular mechanisms underlying the eye's changes with age and region.
Jun 8, 2023
-
Indica Labs Launches Comprehensive Management Service for HALO® Software in AWS Cloud-Hosted Environments
Indica Labs today announces the launch of a service offering deployment and on-going support of its HALO® digital pathology software in a fully managed cloud-hosted environment powered by Amazon Web Services (AWS).
Jun 7, 2023